Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor loading-dose antiplatelet effect in STEMI and NSTEMI
ChiCTR1800014764Phase 4Completed
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ticagrelor in myocardial infarction (MI), sponsored by Zhongshan Hospital, Fudan University. Started Apr 2017; status: completed.
02
Drugs
ticagrelor
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR1800014764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014764.